Company Monitoring Page for Allergan

latest headlines for company on cafepharma

Allergan, Gedeon Richter plan depression submission
BioPharma Dive
Tue, 12/19/17 - 10:21 pm
Tags:
Allergan, Gedeon, clinical depression, Vraylar, acute bipolar depression
8 Takeout targets to watch in 2018
BioPharma Dive
Sat, 12/16/17 - 08:41 am
Tags:
M&A, Allergan, Alnylam, Biomarin, Bristol-Myers Squibb, Incyte, Madrigal Pharmaceuticals, Spark Therapeutics, Sucampo
[forum discussion]A bad move by Allergan
Cafepharma Message Boards
Wed, 12/13/17 - 09:50 am
Tags:
Allergan, Repros, M&A
Allergan buys an ailing Repros, bagging a women’s health drug for the pipeline
Endpoints
Tue, 12/12/17 - 11:18 am
Tags:
Allergan, Repros, M&A, Women's Health
Settle down, Allergan investors. Botox's market share is safe, analysts say
Fierce Pharma
Wed, 12/6/17 - 11:11 am
Tags:
Allergan, Botox, wrinkle treatment, ReVance, RT002
Watch out Allergan: Revance’s wrinkle-reducer beats Botox in PhIII trials
Endpoints
Tue, 12/5/17 - 09:31 am
Tags:
Allergan, ReVance, Botox, clinical trials, RT002, wrinkle treatments
EMA investigates Allergan blockbuster hopeful Esmya on reports of liver damage
Fierce Pharma
Mon, 12/4/17 - 09:32 pm
Tags:
EMA, Allergan, Esmya, Europe, uterine fibroids
Regeneron CEO Schleifer, a year after public Pfizer spat, slams Allergan for tribal deal
Fierce Pharma
Fri, 12/1/17 - 12:39 pm
Tags:
Regeneron, Allergan, Pharma CEOs, Leonard Schleifer, Pfizer, patents, Restasis
Restasis buyers level antitrust lawsuit against Allergan
Drug Delivery Business News
Tue, 11/21/17 - 10:38 pm
Tags:
Restasis, Allergan, antitrust
Allergan could sell women's health for $6B, if it would only agree to split: analyst
Fierce Pharma
Tue, 11/21/17 - 11:46 am
Tags:
Allergan, Women's Health, M&A
[forum discussion] Allergan employees discuss impending cost cuts announced by CEO Saunders
Cafepharma Message Boards
Sun, 11/12/17 - 10:34 am
Tags:
Allergan, Pharma CEOs, Brent Saunders, layoffs
Senators blast Allergan's tribal deal, social contract as 'hypocrisy'
Fierce Pharma
Thu, 11/9/17 - 10:08 am
Tags:
Allergan, Senate, patents
Allergan executives named in investor suit over alleged generics price fixing
Fierce Pharma
Tue, 11/7/17 - 09:57 pm
Tags:
Allergan, investors, generics, drug pricing
Did Allergan lose its $2.1B Kythera bet, or can chin-fat drug Kybella make its mark?
Fierce Pharma
Tue, 11/7/17 - 10:56 am
Tags:
Allergan, Kythera, Kybella
Allergan CEO Saunders claims 'tenacity' led company into tribal licensing deal
Fierce Pharma
Sun, 11/5/17 - 09:37 am
Tags:
Allergan, Pharma CEOs, Brent Saunders, patents, Restasis
Where could Allergan’s cost cuts fall? DTC spending, for starters
Fierce Pharma
Thu, 11/2/17 - 10:22 pm
Tags:
Allergan, DTC advertising
Allergan draws up battle plans as Restasis, other drugs face patent expiries
BioPharma Dive
Thu, 11/2/17 - 09:30 am
Tags:
Allergan, Restasis, patents, generics
How Allergan plc Lost $4 Billion in Q3 and Still Performed Quite Well
Motley Fool
Wed, 11/1/17 - 06:49 pm
Tags:
Allergan, earnings
Cost cuts are coming for Allergan, CEO says. But a breakup isn’t
Fierce Pharma
Wed, 11/1/17 - 06:36 pm
Tags:
Allergan, Pharma CEOs, Brent Saunders, layoffs
Analyst backing an Allergan breakup is undeterred by doubters. Here's why
Fierce Pharma
Mon, 10/30/17 - 02:57 pm
Tags:
Allergan

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.